Chris Liddle
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Liver Disease and Transplantation
- Toxicology top 5%
Papers in ⓘ
-
- Hepatitis C virus research 3
- Co-authors
- GC Farrell (1 shared paper)Prakash Mistry (3 shared papers)Wendy Dangerfield (3 shared papers)Alistair Stewart (3 shared papers)Peter Charlton (3 shared papers)Douglas Bootle (2 shared papers)Jane A. Plumb (1 shared paper)David J. Templeton (1 shared paper)
- Journals
- Hepatology (2 papers)Liver International (1 paper)Journal of Clinical Oncology (1 paper)The Medical Journal of Australia (1 paper)Oncotarget (1 paper)
- Partner nations
- AustraliaNew ZealandUnited Kingdom
In The Last Decade
Chris Liddle
16 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 94
- Hepatology 253
- Toxicology 54
- Epidemiology 531
- Oncology 338
- Endocrinology, Diabetes and Metabolism 169
Countries citing papers authored by Chris Liddle
This map shows the geographic impact of Chris Liddle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Liddle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Liddle more than expected).
Fields of papers citing papers by Chris Liddle
This network shows the impact of papers produced by Chris Liddle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Liddle. The network helps show where Chris Liddle may publish in the future.
Co-authors
The 25 scholars most cited alongside Chris Liddle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 340 | |
| 2 | In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576. | 2001 | 302 |
| 3 | 2000 | 135 | |
| 4 | 2002 | 116 | |
| 5 | 2020 | 62 | |
| 6 | 2002 | 50 | |
| 7 | 2009 | 42 | |
| 8 | 1998 | 41 | |
| 9 | 1987 | 22 | |
| 10 | 2013 | 20 | |
| 11 | 2003 | 18 | |
| 12 | 2013 | 16 | |
| 13 | 2016 | 15 | |
| 14 | 2005 | 14 | |
| 15 | 2007 | 8 | |
| 16 | 2010 | 1 |
About Chris Liddle
Chris Liddle is a scholar working on Hepatology, Toxicology, Geriatrics and Gerontology, Pharmacology and Pathology and Forensic Medicine, having authored 16 papers that have together received 1.2k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (7 papers), Cancer therapeutics and mechanisms (3 papers), Hepatitis C virus research (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Pharmacogenetics and Drug Metabolism (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers) and Hepatitis B Virus Studies (2 papers). The work is most often cited by research in Hepatology (253 citations), Toxicology (54 citations), Epidemiology (531 citations), Oncology (338 citations) and Endocrinology, Diabetes and Metabolism (169 citations). Chris Liddle has collaborated with scholars based in Australia, New Zealand and United Kingdom. Frequent co-authors include GC Farrell, Prakash Mistry, Wendy Dangerfield, Alistair Stewart, Peter Charlton, Douglas Bootle, Jane A. Plumb, David J. Templeton, Dev Samarasinghe and Rita Lin. Their work appears in journals such as Hepatology, Liver International, Journal of Clinical Oncology, The Medical Journal of Australia and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.